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The aim of this study was to investigate the 
incidence and risk factors of peripherally 
inserted central venous catheters (PICCs) 
in critically ill premature neonates; A 
retrospective analysis of 30 infants with 
very low and extremely low birth weights 
(VLBW, ELBW) who underwent PICC 
placement over a three-year period, from 
January 2012 till January 2015. Gestational 
age, birth weight (BW), sex, site of catheter 
placement, reason for catheter removal, 
duration of catheter use, proven sepsis, 
type of reported organism and rate of 
complications were collected. The infants 
were classified into two groups according 
to BWs: Group 1—VLBW infants (BW be-
tween 1,000 and 1,500 g) and Group 2—
ELBW infants (BW <1,000 g). During the 
study period PICCs were attempted in 40 
patients. A PICC was successfully inserted 
into 30 patients (75%). PICCs placed in 
either the upper or the lower extremity. 
There were no differences in complication 
rates. The median time of catheter inser-
tion was 13 (1-35) days for Group 1 and 11 
(6-19) days for Group 2. The median du-
ration of PICCs was 10.5 (2-16) and 12.2 
(3-25) days. Statistical analysis showed that 
there was a significant difference between 
the groups for both catheter insertion day 
and mean duration of PICCs (p= 0.241, 
respectively). There were no significant 
differences between groups for the reasons 
for catheter removal (p=0.598). PICCs are 
convenient for the administration of long 
course antibiotics and parenteral nutrition 
for both VLBW and ELBW infants, but 
there are many risks associated with the 
insertion of PICCs, including serious and 
fatal complications.
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INTRODUCTION
Since their early descriptions over two dec-
ades ago, percutaneously inserted central 
catheters (PICCs) have become a mainstay 
in neonatal intensive care units for long-
term venous access to deliver parenteral 
nutrition and medications. (1, 2) Periph-
erally inserted central venous catheters 
(PICCs) are widely used and are valuable 
in the management of VLBW and ELBW 
infants. PICCs provide an important route 
to deliver TPN, hyperosmolar solutions, 
cardiac inotropic agents and some medi-
cations or solutions that are considered as 
chemical irritants, especially when these 
premature infants are experiencing tempo-
rarily inadequate gastrointestinal tractin-
take. Also, decrease in stress and suffering 
associated with the handling of the infant 
with multiple peripheral intravenous lines 
start again. (3) Approximately 8.3-33% of 
neonates admitted to an intensive care unit 
require PICC insertion. (4) The presence 
of an indwelling PICC also has relevant 
risks and morbidity, including vascular 
compromise, pleural and pericardial ef-
fusion, cardiac tamponade, obstruction, 
thrombosis, catheter-related sepsis (CRS), 
leakage, catheter migration, vegetations 
and phlebitis. (5)
MATERIALS AND METHODS
This study was conducted in a tertiary-lev-
el NICU at the Children’s Hospital, Banja 
Luka, Bosnia and Hercegovina. Neonates 
with less than 1,500 g body weight and 
with a PICC for maintenance of intrave-
nous fluid, antibiotics or TPN were eligi-
ble for enrolment. Patients were classified 
into two groups according to their BWs: 
Group 1 consisted of VLBW infants with 
BWs between 1,000 and 1500 g, and Group 
2 consisted of VLBW neonates with a BW 
<1,000 g (ELBW group).
PICC placement and management
A percutaneous central catheter (Nutriline 
Twinflow 2Fr, Vygon, Paris, France) was 
used in all patients. Fentanyl (1-2 µg/kg) 
was used for analgesia of the infant. Cathe-
ters were introduced aseptically, including 
the use of sterile gowns, caps and masks 
during the placement. Hand hygiene was 
performed with antiseptic-containing 
soap, and skin was disinfected with 70% 
alcohol before catheter insertion. All cath-
eters were inserted by blind cannulation. 
Prior to insertion, the catheter length was 
measured according to the indwelling vein. 
The catheter was inserted via a pileable mi-
coflush needle into an appropriate vein in 
the absence of any clinical sign of infection. 
The position of the catheters were con-
firmed radiografically. The catheters were 
secured with sterile adhesive strips and 
covered with sterile transparent adhesive 
dressing. Both the sterile adhesive strips 
and the transparent dressing were changed 
every seven days or when necessary. Data 
were collected retrospectively over a three-
year period. Informed consent was ob-
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tained from parents for PICC placement. 
The data included gestational age, BW, 
sex, site of catheter placement, reason for 
catheter removal, duration of catheter use, 
proven sepsis and type of the reported or-
ganism and rate of complications. Mortal-
ity during catheterization was also record-
ed. Catheter-related complications were 
categorized into three groups: mechanical, 
infectious and death. The withdrawal of 
the catheters were done when infants were 
tolerating full enteral feedings or if a pro-
longed intravenous medication course was 
completed. The PICCs were also removed 
if there were any signs of complications. 
The tips of the catheters were cultured rou-
tinely after the catheters were removed. If 
a bacterial growth was detected in the tip 
of a catheter without any clinical deteriora-
tion or without a positive blood culture, it 
was defined as bacterial colonization of the 
catheter. When clinical signs of sepsis were 
observed, a blood sample was drawn from 
a peripheral vein for blood culture. If a 
bacterial growth was detected in the blood 
culture, the PICC was removed and the 
tip of the catheter was cultured. CRS was 
defined as clinical deterioration and posi-
tive blood culture with the same microor-
ganism present on the catheter tip and a 
clinical and microbiological absence of any 
other source of infection. The incidence 
rate of CRS was expressed as the number 
of infections per 1,000 catheter days.
Statistical analysis
Statistical Package for Social Sciences for 
Windows (SPSS version 15.0, SPSS Inc., 
Chicago, IL, USA) was used to process 
data and statistics. Data were expressed 
as mean ± standard deviation (SD). The 
Mann-Whitney U-test was used to analyze 
the gestational age, BW, duration of PICCs 
patency and catheter insertion age. The 
Fischer exact test and Pearson Chi-square 
tests were used to analyze mechanical and 
infectious complications and death rate. P 
value < 0.05 was considered to be statisti-
cally significant.
RESULTS
During the study period PICCs were at-
tempted in 40 patients. A PICC was suc-
cessfully inserted into 30 patients (75%). 
There were no insertion-related complica-
tions in the study group. Only two infants 
required multiple PICCs for prolonged 
treatment. The insertion locations of the 
catheters were in the upper extremity in 12 
PICCs (40%), and in the lower extremity 
in 18 PICCs (60%). There were 12 infants 
were in Group 1 and 18 in Group 2. 
Descriptive data of the patients and the 
study are provided for in  I. The median 
time of catheter insertion was 13 (1-35) 
days for Group 1 and 11 (6-19) days for 
Group 2. The median duration of PICCs 
was 10.5 (2-16) and 12.2 (3-25) days. Sta-
tistical analysis showed that there was a 
significant difference between the groups 
for both catheter insertion day and mean 
duration of PICCs (p= 0.241, respectively). 
The reasons for the removal of the cath-
eters were: (a) completion of intravenous 
therapy in 10 cases (33.3%), (b) occlusion 
in 11 cases (36.6%), (c) leakage in 3 cases 
(10%), (d) CRS in 5 cases (16.6%), (e) phle-
bitis in 1 case (3.3%) and (f) death in 2 cas-
es (6.6%). Bacterial colonization without 
systemic infection was found in 2 patients. 
CRS was found in 5 patients. Coagulase-
negative Staphylococcus epidermidis was 
found in 3 patients, Candida albicans in 1 
patient and Klebsiela pneumoniae spp in 
1 patient. The incidence rate of CRS was 
found to be 13.47 per 1,000 catheter days. 
There were no statistically significant dif-
ferences in the number of complication 
rates relating to the insertion location. Two 
infants died during the study. Both of them 
were in the ELBW group. One of them died 
due to intracranial haemorrhage, and the 
second infants died due to PICC compli-
cations (C. Albicans infection). There were 
significant differences between groups for 
the reasons of removal (p=0.598). The rea-
sons for the removal of PICCs in relation 
to the groups are presented in table 2.
DISCUSSION
PICCs have been increasingly used in 
premature infants in order to provide ad-
equate parenteral nutrition, and adminis-
tration of antibiotics and fluids. In the cur-
rent study, the median duration in place of 
PICCs was 12.7 and 11 days for VLBW and 
ELBW infants, respectively. 
Several studies have reported a significant 
number of complications due to PICCs. 
Some of them are major and potentially fa-
tal, such as thrombosis, extravascular col-
lection of fluid in the thorax, pericardial 
tamponade and perforation of the myo-
cardium, pulmonary embolism, sepsis and 
death. (4 - 6) Mechanical complications of 
PICCs reported in previous studies includ-
ed occlusion, accidental removal, leakage 
or breakage, catheter migration and phle-
bitis. (4 -7) The PICC-related mechanical 
complication rates are reported in a wide 
range from 0% to 48% . (1, 2, 4, 7, 8) As 
in other published studies, our study found 
that occlusion was the most common com-
plication (36.6%). Using the smallest PICC 
in the largest vein, adding heparin to the 
intravenous fluid and running fluids con-
tinuously are useful strategies for prevent-
ing occlusion. (9) Phlebitis was accepted in 
the presence of linear red streak developed 
along the superficial veins from the inser-
tion site that occurred in 1 (5.5%) patients. 
CRS is defined as clinical deterioration 
and a positive blood culture with the same 
microorganism present on the catheter tip 
and clinical and microbiological absence 
of any other source of infection. PICC-re-
lated sepsis rate ranged from 0% to 29% of 
placed catheters, resulting in 0.3 to 16.7 per 
1,000 catheter days. (10) Suresh and Ed-
wards reported CRS rates of 2.7 and 3.7 per 
1,000 catheters days for VLBW and ELBW 
infants, respectively. (11, 12) Parellada et 
al and Cairns et al reported CRS rates of 
8.21 per 1,000 catheter days, respectively. 
In both cases, the study populations had 
similar BWs and gestational ages as in our 
study. (13, 14) The CRS rate in our study 
was 13.47 per 1,000 catheter days. There 
was a significant difference in the VLBW 
and ELBW groups since the two deaths we 
had in our study were in the ELBW group. 
Our results confirm previous studies that 
coagulase-negative S. epidermidis was the 
major organism associated with CRS. (5, 
8, 9, 12) Low BW, lesser gestational age, 
longer duration of PICC and femoral site 
insertion were previously reported to in-
crease the risk of CRS. (9, 15, 16) In our 
study, there were no statistically significant 
differences in the number of complication 
rates in relation to the insertion site. Also, 
the rate of complication of PICCs was not 
higher in infants with BW <1,000 g (ELBW 
group) than in infants with BW 1,000-
1,500 g (VLBW group). The prevention of 
CRS is one of the priorities of most NICUs 
because of the potential for reductions in 
mortality, morbidity and hospitalization 
days. 
There are some limitations to our study. 
The PICCs have very narrow diameters 
(1 or 2 Fr), and therefore these catheters 
could not be used for blood sampling or 
blood products transfusions. We could 
not collect a blood culture from the cath-
eters. Therefore, the tips of the catheters 
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were cultured from patients whose blood 
cultures were positive for bacterial growth. 
The incidence of failure at insertion and 
mechanical irreversible occlusion were 
high in our study. Ultrasound guidance 
and the use of near-infrared devices may 
reduce the rate of insertion failure, but we 
did not utilize these techniques. Heparin 
was not added routinely in maintenance 
fluids, TPN and lipid solutions but we 
flushed the catheters with heparin 10IU/
ml every six hours or as necessary.
CONCLUSION 
This study confirmed that PICCs represent 
a suitable intravenous route for the admin-
istration of long course antibiotics and par-
enteral nutrition in premature neonates. 
Mechanical complications were the most 
common reason for removal. As in other 
published studies, our study found that 
occlusion was the most common compli-
cation (36.6%). There were no statistically 
significant differences in the number of 
complication rates according to the inser-
tion site. The ELBW group was increased 
risk of catheter complications in our study. 
It is important to emphasize the fact that 
CRS per 1000 catheter days was increased 
(13.47/1000 days) probably due to limited 
conditions. There are many risks associ-
ated with the insertion of PICCs including 
serious and fatal complications.
Table 1. Demographic characteristics of the groups
Group 1 (n=12) 
Mean (min-max)
Group 2 (n=18) 
Mean (min-max)
p-Value
Gestational age (wk) 30.7(28-34) 28.1 (25-33) 0.00634
Birth weight (g) 1220.8(1050-1450) 824.4 (670-990) 0.002
Male/female 7/5 11/7 0.879072
Catheter insertion age (day) 10.5(2-16) 12.2 (3-25) 0.24196
Duration of catheter (day) 12.7 (5-30) 11.0 (3-30 ) 0.19215






No longer required 5 (41.6 %) 5 (27.7 %) 0.429195
Occlusion 4 (33.3 %) 7 (38.9 %) 0.75706
Leakage 1 ( 8.3 %) 2 ( 11.1 %) 0.803785
Phlebitis 0 (0%) 1 (5.5%) 0.406282
Catheter-related sepsis 2 ( 16.6 % ) 3 (16.6 %) 1
Catheter-related death 0 (0%) 1 (5.5 %) 0.406282
Overall mortality* 0 (0%) 2 (11.1 %) 0.231998
*Overall mortality = Catheter-related plus noncatheter-related death
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